Quantcast
Home > Quotes > VXRT

Vaxart, Inc Common Stock (VXRT) Quote & Summary Data

VXRT 
$0.6421
*  
0.0053
0.82%
Get VXRT Alerts
*Delayed - data as of Aug. 16, 2019  -  Find a broker to begin trading VXRT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
4
Today's High / Low
$ 0.65 / $ 0.634
Share Volume
45,602
50 Day Avg. Daily Volume
146,323
Previous Close
$ 0.6474
52 Week High / Low
$ 7.60 / $ 0.55
Market Cap
10,136,020
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.63

Intraday Chart

Shares Traded

Share Volume:
45,602
50 Day Avg. Daily Volume:
146,323

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.18

Trading Range

The current last sale of $0.6421 is 16.75% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.65 $ 7.60
 Low: $ 0.634 $ 0.55

Company Description (as filed with the SEC)

Vaxart Biosciences, Inc. was originally incorporated in California in March 2004, under the name West Coast Biologicals, Inc. and changed its name to Vaxart, Inc., or Private Vaxart, in July 2007, and reincorporated in the state of Delaware. On February 13, 2018, Private Vaxart completed a reverse merger, or the Merger, with Aviragen Therapeutics, Inc., or Aviragen, pursuant to which Private Vaxart survived as a wholly owned subsidiary of Aviragen. Under the terms of the Merger, Aviragen changed its name to Vaxart, Inc. and Private Vaxart changed its name to Vaxart Biosciences, Inc. Unless otherwise indicated, all references to "Vaxart," "we," "us," "our" or the "Company" in this Annual Report on Form 10-K mean Vaxart, Inc., the combined company. We are a clinical-stage biotechnology company focused on the development of oral recombinant vaccines based on our proprietary oral vaccine platform.  ... More ...  



Risk Grade

Where does VXRT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.65
Open Date:
Aug. 16, 2019
Close Price:
$ 0.65
Close Date:
Aug. 16, 2019


Consensus Recommendation

Analyst Info